Our people
Leadership with experience across research, clinical development, global commercialization, finance and company building.
Management
Founder, Chief Executive Officer & Board Member. Previously co-founded and led Y-mAbs Therapeutics, securing its 2018 IPO and 2020 FDA approval of Danyelza. His earlier BioPharma leadership also includes OXiGENE and Genmab.
VP, Chief Development Officer.
Board Member & SVP, Chief Operating Officer. More than 20 years of international strategic management experience as a manager and executive, with commercial and branding expertise.
Senior Financial Director.
VP, Business Development & Medical Network.
Governance
The board brings strategic insight across medical research, clinical development, commercial strategy, regulatory affairs and corporate finance.
| Name | Role | Experience |
|---|---|---|
| Dr. Ole Baadsgaard | Chairman | Former Chief Medical Officer at Genmab A/S and Y-mAbs Therapeutics, Inc.; author or contributor to more than 100 peer-reviewed publications and author on more than 20 patents and patent applications. |
| Dr. Claus J. Møller-San Pedro | Board Member & CEO | Founder and CEO of AFYX; previously co-founder and CEO of Y-mAbs, securing its IPO in 2018 and FDA approval of Danyelza in 2020. |
| Pia Møller-San Pedro | Board Member | More than 20 years of international strategic management and executive experience, with commercial and branding expertise. |
| Søren Kjær | Board Member | More than 30 years of international banking experience, including venture capital investments and board positions in Life Science and venture capital companies. |
Chairman. Former Chief Medical Officer at Genmab and Y-mAbs Therapeutics.
Founder, Board Member & Chief Executive Officer. Co-founder of OXiGENE, Genmab and Y-mAbs Therapeutics.
Board Member with over 20 years of international management, commercial and branding experience.
Board Member with more than 30 years in international banking and experience in venture capital and Life Science boards.
Working together
Our leadership and partners bring complementary disciplines together to support rigorous development and thoughtful commercialization.
Learn about the company
